Nuvalent reported a net loss of $33.6 million for the third quarter of 2023. The company's cash, cash equivalents, and marketable securities totaled $413.3 million as of September 30, 2023, which, combined with the proceeds from a recent public offering, are expected to extend the operating runway into 2027.